{"nct_id":"NCT05444530","title":"A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative Neoplasms","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2022-07-21","start_date_type":"ACTUAL","primary_completion_date":"2025-06-24","primary_completion_date_type":"ACTUAL","completion_date":"2025-06-24","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["JNJ"]}